MAGIC Ruxolitinib for aGVHD
MAGIC Ruxolitinib for aGVHD
Recruiting · NCT06936566 · Registry updated 2026-03-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MAGIC Ruxolitinib for aGVHD | Acute Graft-versus-host Disease; Adverse Effects; Allogeneic Bone Marrow Transplantation | Recruiting | Phase 2 | 2026-03-23 | NCT06936566 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Incyte Corporation | 153 |
| John Levine | 1 |
| National Cancer Institute (NCI) | 3015 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope Comprehensive Cancer Center | Duarte | United States | 263 |
| Dana Farber Cancer Institute | Boston | United States | 133 |
| Fred Hutchinson Cancer Research Center | Seattle | United States | 71 |
| Icahn School of Medicine at Mount Sinai | New York | United States | 342 |
| Kansas University Medical Center | Fairway | United States | 3 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Mayo Clinic | Rochester | United States | 664 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| Ohio State University | Columbus | United States | 169 |
| University of Pennsylvania | Philadelphia | United States | 507 |
| Vanderbilt University | Nashville | United States | 16 |
| Washington University | St Louis | United States | 182 |
| Winship Cancer Institute, Emory University | Atlanta | United States | 47 |